
|Articles|April 5, 2011
ACC 2011 Interview on Cost Analysis Substituting Dabigatran for Warfarin
Dr. Julie Atay discusses her poster at ACC 2011 on "Cost Analysis of Substituting Dabigatran for Warfarin in an Anticoagulant Management Program."
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Real-World Safety Signals of Bimekizumab Emerge in New FAERS Analysis
2
Blinatumomab Boosts Survival in Pediatric ALL, but Faces Delivery Hurdles
3
Legal Issues in Value-Based Care Contracts for Self-Insured Employers
4
ICYMI: Highlights From AACR 2025
5









































